Lung Transplant Immunosuppression — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Rituximab only
Standard lung transplant immunosuppression comprises triple therapy: a calcineurin inhibitor (tacrolimus or ciclosporin), an antimetabolite (mycophenolate mofetil or azathioprine), and corticosteroids. Induction therapy with basiliximab (IL-2 receptor antibody) or anti-thymocyte globulin is also commonly used perioperatively. The anaesthetic and ICU implications include increased infection risk, drug interactions (tacrolimus with volatile agents, ciclosporin with muscle relaxants), and renal toxicity monitoring.
Reference: NICE – 2019 – Organ transplant immunosuppression; RCOA – 2023 – Cardiothoracic/transplant module